Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /TILT
chevron_leftBack
TILT Holdings Inc. logo

TILT Holdings Inc.

TILT
NEO: TILT Delayed
0.0100CAD 0%
0.0072 USD
As of 13 June 2026, TILT Holdings Inc. has a market cap of $2.8M USD, ranking #46359 globally and #5883 in the United States. It ranks #4108 in the Healthcare sector, and #303 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
46359
Country Rank
5883
Sector Rank
4108
Industry Rank
303
Key Stats
Market Cap
$2.8MUSD
3.91M CAD
Enterprise Value
$96.1MUSD
134.09M CAD
Revenue (TTM)
$91.83MUSD
128.37M CAD
EBITDA (TTM)
-$8.74MUSD
-12.19M CAD
Net Income (TTM)
-$77.44MUSD
-108.26M CAD
EBITDA Margin
-9.5%
Profit Margin
-84%
PS Ratio
0.0
PB Ratio
0.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Tim Conder open_in_new
Employees
313
Founded
2011
Website
tiltholdings.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% 100% 0% 100% 100%

News

Loading...

Markets

Exchange Ticker Price
Cboe Canada
MIC: NEOE
PRIMARY
TILT
TILT Holdings Inc
ISIN: CA88688R1047
Shares Out.:
347.501M1 Shares Float: 324.863M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0100 CAD
OTC Markets
MIC: OTCM
TLLTF
TILT Holdings Inc
ISIN: CA88688R1047
Shares Out.:
347.44M1 Shares Float: 320.983M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0060 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About TILT Holdings Inc.

TILT Holdings Inc. provides various cannabis products and services in the United States, Canada, and internationally. It operates through two segments: Cannabis and Accessories. The company produces, cultivates, extracts, and sells cannabis products. It also manufactures and distributes electronic and non-nicotine devices and systems. In addition, the company provides medical cannabis products, including tinctures, vape cartridges, syringes, topicals, concentrates, edibles, cannabis flowers, and capsules. TILT Holdings Inc. was founded in 2011 and is headquartered in Phoenix, Arizona.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
1M%
-
INDV
$2.07B
1.54B GBP
74K%
-
NDOI
$1.8B
64K%
0.4
$1.76B
63K%
-
$1.33B
47K%
-
$1.02B
36K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$36.75B
108.92B ILS
1M%
24.2
$15.84B
107.34B CNY
566K%
16.0
CIPLA
$11.16B
1.06T INR
399K%
23.4
LUPIN
$11.04B
1.05T INR
394K%
22.7
$9.09B
61.6B CNY
325K%
80.6
$8.74B
7.57B EUR
312K%
-
chevron_leftBack